Matsuo So
Overview
Explore the profile of Matsuo So including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salguero B, Agrawal A, Kaul V, Lo Cascio C, Joy G, So M, et al.
Respir Med
. 2024 Mar;
225:107599.
PMID: 38492817
Background: Central airway obstruction (CAO) can lead to acute respiratory failure (RF) necessitating positive pressure ventilation (PPV). The efficacy of airway stenting to aid liberation from PPV in patients with...
2.
So M, Chaddha U, Shojaee S, Lee P
Curr Opin Pulm Med
. 2023 Nov;
30(1):84-91.
PMID: 37962206
Purpose Of Review: The purpose of this review is to elaborate on the role of medical thoracoscopy for various diagnostic and therapeutic parietal pleural interventions. The renewed interest in medical...
3.
Salguero B, Agrawal A, Lo Cascio C, So M, Chaddha U
Respir Med
. 2023 Jun;
216:107320.
PMID: 37301524
Background: Airway stent removal has traditionally been associated with a high complication rate. Most studies on stent removal are over a decade old, prior to newer anti-cancer therapies, and by...
4.
Ishisaka Y, Watanabe A, Fujisaki T, Iwagami M, So M, Steiger D, et al.
Catheter Cardiovasc Interv
. 2023 Jun;
102(2):249-265.
PMID: 37269229
Background: Multiple interventions, including catheter-directed therapy (CDT), systemic thrombolysis (ST), surgical embolectomy (SE), and therapeutic anticoagulation (AC) have been used to treat intermediate to high-risk pulmonary embolism (PE), but the...
5.
So M, Shachi T, Mudd J, Miyakawa L, Kim B
BMJ Case Rep
. 2023 May;
16(5).
PMID: 37160375
A man in his 60s presented with intermittent constitutional symptoms along with waxing and waning chest radiographic abnormalities, eventually leading to a diagnosis of lymphomatoid granulomatosis (LYG). LYG is a...
6.
Watanabe A, So M, Iwagami M, Fukunaga K, Takagi H, Kabata H, et al.
Respirology
. 2022 Jun;
27(8):605-616.
PMID: 35694728
Coronavirus disease 2019 (COVID-19) often causes radiological and functional pulmonary sequelae. However, evidence on 1-year follow-up of pulmonary sequelae is limited. We aimed to investigate the characteristics and time-course of...
7.
Watanabe A, So M, Mitaka H, Ishisaka Y, Takagi H, Inokuchi R, et al.
Mycopathologia
. 2022 Mar;
187(2-3):271-289.
PMID: 35312945
The recent increase of COVID-19-associated mucormycosis (CAM) has been commanding global attention. However, basic epidemiologic characteristics have not firmly been established. In this systematic review and meta-analysis, we sought to...
8.
So M, Takahashi M, Miyamoto Y, Ishisaka Y, Iwagami M, Tsugawa Y, et al.
Diabetes Metab Syndr
. 2022 Jan;
16(1):102373.
PMID: 34979344
Background And Aims: Obesity has been reported to be one of the most frequent comorbidities in COVID-19 patients and associated with higher rates of in-hospital mortality compared to non-obese patients....
9.
Kuno T, Takahashi M, So M, Egorova N
J Cardiol
. 2022 Jan;
79(4):489-493.
PMID: 34974942
Background: Severe coronavirus disease 2019 (COVID-19) is associated with systematic coagulopathy which might result in fatality. We aimed to investigate whether systematic anticoagulation before admission with COVID infection was associated...
10.
Kuno T, So M, Iwagami M, Takahashi M, Egorova N
J Cardiol
. 2022 Jan;
79(4):494-500.
PMID: 34974938
Background: Statins are frequently prescribed for patients with dyslipidemia and diabetes mellitus. These comorbidities are highly prevalent in coronavirus disease 2019 (COVID-19) patients. Statin's beneficial effect on mortality in COVID-19...